Company Active LTD

Company profile

Screenin3D Limited

3D Primary Model Screening Partner | ScreenIn3D

Precision medicine and drug development based on maximising screening of limited human cancerous tissue with 3D microfluidic technology

CRN

SC614453

Founded

2018

Age

Overview

Legal name

SCREENIN3D LIMITED

Region

Unknown

Registered address

TECHNOLOGY AND INNOVATION CENTRE

99 GEORGE STREET

GLASGOW

UNITED KINGDOM

G1 1RD

Insolvency history

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FULLACCOUNTS

Turnover

Unknown

Profit / Loss

Unknown

Employees

Company events

Reference milestones and recent Companies House filing stream events.

6 events

30 Sep

2027

Accounts due

Accounts Due

Next accounts due date

05 Dec

2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec

2025

Accounts filed

Accounts

Last accounts made up date

21 Nov

2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

21 Nov

2024

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzQ0NDQxNTE0NWFkaXF6a2N4

Published 21 Nov 2024 10:07

22 Nov

2018

Incorporated

Inception

Company registered at Companies House

Public funding

1 award

First funded

2022

Funded years

2022

Age at first award

3 years

Projects

2022 EU-Funded Lead participant

A novel therapeutic antibody to improve cancer treatment through the elimination of senescent cells

1 Jun 2022 to 31 May 2024

Awarded

£101,564

Total cost £169,274

Product types

EU-Funded